Icon

Bunavail - (Buccal Film 6.3 mg/1 mg)

Buprenorphine and Naloxone Biodelivery Sciences
Buccal Film 6.3 mg/1 mg
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
Indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support.
Yes
******* ** *** ***** ** **** **** ** **** ******* '*** (*** **, ****), '*** (**** **, ****), '*** (*** **, ****) *** *** ************ *********. ** ****** **** **** ******* ****** ** **** ****. ************ **** ***** **** ** **** '*** (*** **, ****) *** *** *********.
Bunavail Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
**** ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ********* **** *, **** ******* **** *** ****** **** ****
  1. *** *, **** : ******* ******** *********** ******** *** ***** *** ***** *** **** ** **** ******* '*** (*** **, ****), '*** (**** **, ****), '*** (*** **, ****), '*** (***** **, ****)
  2. *** **, **** : **** ******** *********** ******** *** ***** ********* **** ** **** ** ****** ********* (*** **, ****),******* (**** **, ****), ******* (*** **, ****), ******* (***** **, ****)
  3. *** **, **** : *********** ******** *** ***** ***** * **** ******* ******* ** ******** ***** ** ********.
  4. *** *, **** : *********** ******** *** ***** ***** * **** ******* **** ** ******** ***** ** ********.
  5. *** **, **** : ********** ********* **** ****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.